Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Hormonal Contraception in Men
pp. 249-257(9)
Authors: Walton, M.; Anderson, R. A.

Signaling Processes in Tumoral Neuroendocrine Pituitary Cells as Potential Targets for Therapeutic Drugs
pp. 259-267(9)
Authors: Paez-Pereda, M.; Giacomini, D.; Echenique, C.; Stalla, G. K.; Holsboer, F.; Arzt, E.

Caspases as Drug Targets in Ischemic Organ Injury
pp. 269-287(19)
Authors: Faubel, S.; Edelstein, C. L.

Role of FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases
pp. 289-303(15)
Authors: Rizzo, G.; Renga, B.; Mencarelli, A.; Pellicciari, R.; Fiorucci, S.

Estrogen Receptor Signalling: Bases for Drug Actions
pp. 305-314(10)
Authors: Marino, M.; Acconcia, F.; Ascenzi, P.

Therapeutic Potential of Glycolipid Ligands for Natural Killer (NK) T Cells in the Suppression of Autoimmune Diseases
pp. 315-322(8)
Authors: Miyake, S.; Yamamura, T.

From Molecular Footprints of Disease to New Therapeutic Interventions in Diabetic Nephropathy: A Detective Story
pp. 323-329(7)
Authors: Miyata, T.; Kurokawa, K.; de Strihou, C.van Y.

Functional Foods: Salient Features and Clinical Applications
pp. 331-337(7)
Authors: Riezzo, G.; Chiloiro, M.; Russo, F.

Drug Targets in Colonoscopic Polypectomy: Biological Sealants with Special Reference to Fibrin-Glue (Tissucol)
pp. 339-345(7)
Author: Venezia, P.

Advances in Osteoclast Differentiation and Function
pp. 347-355(9)
Author: Abu-Amer, Y.